Novo Nordisk Recalls Saxenda Injection Samples Due to Temperature Abuse
Novo Nordisk is recalling Saxenda (liraglutide) injection samples that were stored below 32°F. The temperature abuse may cause lack of efficacy and damage to the cartridge and pen-injectors.
- Product
- SAXENDA — SAXENDA (LIRAGLUTIDE)
- Category
- Drug
- Distribution
- Distributed nationwide